GSEA revealed upregulation of pathways including platelet activation, fluid shear stress and atherosclerosis, and Rap1 signaling, alongside downregulation of PI3K-Akt and mTOR signaling in patients with PAS. This evidence concerns the gene AKT1 and atherosclerosis.